| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2011 | WO2011054841A1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 05/12/2011 | WO2011054834A1 Benzimidazole-imidazole derivatives |
| 05/12/2011 | WO2011054828A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | WO2011054820A1 Methods and compositions for the treatment of white matter ischemia |
| 05/12/2011 | WO2011054811A1 Rna antagonists targeting hsp27 combination therapy |
| 05/12/2011 | WO2011054805A1 Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions |
| 05/12/2011 | WO2011054773A1 Novel lactam compounds |
| 05/12/2011 | WO2011054759A1 New therapeutic approaches for treating alzheimer disease |
| 05/12/2011 | WO2011054733A1 Process for preparing aminale and their use for preparing 1,3-disubstituted pyrazole compounds |
| 05/12/2011 | WO2011054732A1 Process for preparing 1,3-disubstituted pyrazole compounds |
| 05/12/2011 | WO2011054659A1 Exon skipping therapy for dysferlinopathies |
| 05/12/2011 | WO2011054620A1 Combinations of a pi3k inhibitor and a mek inhibitor |
| 05/12/2011 | WO2011054553A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | WO2011054525A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 05/12/2011 | WO2011054433A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | WO2011054399A1 Improvement of the glucocorticoid receptor function in asthma |
| 05/12/2011 | WO2011054315A1 Use of cyr61 protein for preparing medicine |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011054292A1 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof |
| 05/12/2011 | WO2011054289A1 Epirubicin derivatives |
| 05/12/2011 | WO2011054190A1 Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof |
| 05/12/2011 | WO2011054185A1 Optical isomers of aralkyl piperazine derivative, preparation methods and uses thereof |
| 05/12/2011 | WO2011054182A1 Sodium transhinone iia sulfonate hydrate and preparation method and use thereof |
| 05/12/2011 | WO2011054179A1 Crystalline form of cladribine and process for preparation thereof |
| 05/12/2011 | WO2011054174A1 Depolymerized fucosylated glycosaminoglycan and preparation method thereof |
| 05/12/2011 | WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof |
| 05/12/2011 | WO2011054103A1 Use of synergistic combinations of an avermectin and an antineoplastic compounds for the treatment of hematological malignancies |
| 05/12/2011 | WO2011054087A1 Stable pharmaceutical formulations comprising lubiprostone |
| 05/12/2011 | WO2011054068A1 Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals |
| 05/12/2011 | WO2011054033A1 Combination therapies employing non-ablative light and topical agents |
| 05/12/2011 | WO2011037854A3 Methods for producing hydrocodone, hydromorphone or a derivative thereof |
| 05/12/2011 | WO2011034834A3 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 05/12/2011 | WO2011034509A3 New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases |
| 05/12/2011 | WO2011027081A3 Derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof |
| 05/12/2011 | WO2011018771A3 Process for the preparation of valganciclovir hydrochloride |
| 05/12/2011 | WO2011017521A3 Bicyclic cyclohexose nucleic acid analogs |
| 05/12/2011 | WO2011013909A9 Composition containing oligo-hyaluronic acid for promoting the stemness of skin cells and for stimulating differentiation |
| 05/12/2011 | WO2011009115A3 Combination therapies for the treatment of obesity |
| 05/12/2011 | WO2011008823A3 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 05/12/2011 | WO2011008730A3 Chemical modification of small hairpin rnas for inhibition of gene expression |
| 05/12/2011 | WO2011008490A3 Combination therapies for the treatment of obesity |
| 05/12/2011 | WO2011008230A3 Rapamycin derivatives and ethers of n-propanolamines and uses related to infection |
| 05/12/2011 | WO2011005969A3 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/12/2011 | WO2011005853A3 Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome |
| 05/12/2011 | WO2011005759A3 Lonidamine analogues for fertility management |
| 05/12/2011 | WO2011005749A3 Topical antifungal composition |
| 05/12/2011 | WO2011005473A9 Methods for treating or preventing fatigue |
| 05/12/2011 | WO2011001400A3 Processes for the preparation of form i and form ii of palonosetron hydrochloride |
| 05/12/2011 | WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors |
| 05/12/2011 | WO2010151710A3 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 05/12/2011 | WO2010151541A8 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 05/12/2011 | WO2010150098A3 Use of quingolide in the treatment of endometriosis, pain and cancer |
| 05/12/2011 | WO2010149384A3 Hybrid molecules made of lipids and lipid-analogous compounds and use thereof as pharmaceutical or cosmetic preparation |
| 05/12/2011 | WO2010148138A3 Camptothecin derivatives |
| 05/12/2011 | WO2010148012A3 Hemostatic material and delivery device |
| 05/12/2011 | WO2010147898A3 Small molecule inhibitors of spleen tyrosine kinase (syk) |
| 05/12/2011 | WO2010144339A3 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
| 05/12/2011 | WO2010135695A3 TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3 |
| 05/12/2011 | WO2010129861A3 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 05/12/2011 | WO2010060624A3 Dry processing and novel forms of lacosamide |
| 05/12/2011 | WO2010046663A3 Novel uses |
| 05/12/2011 | WO2010032266A9 Novel single unit carbapenem aminoglycoside formulations |
| 05/12/2011 | WO2010017273A3 Tigecycline formulations |
| 05/12/2011 | WO2009140621A8 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | WO2008079988A9 Quinazolines for pdk1 inhibition |
| 05/12/2011 | US20110112618 Drug eluting composite |
| 05/12/2011 | US20110112467 Systems and methods for improving image-guided tissue ablation |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112259 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 05/12/2011 | US20110112201 Hydroxytyrosol benefits mitochondria |
| 05/12/2011 | US20110112200 Solid states of o-desmethylvenlafaxine salts |
| 05/12/2011 | US20110112199 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/12/2011 | US20110112198 Compositions for enhancing hair growth |
| 05/12/2011 | US20110112197 Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide |
| 05/12/2011 | US20110112196 Nrf2 screening assays and related methods and compositions |
| 05/12/2011 | US20110112195 Potent and Selective Inhibition by Aurinticarboxylic Acid |
| 05/12/2011 | US20110112194 Medicaments Containing Pantothenic Acid |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112192 Verfahren zur geruchsextinktion |
| 05/12/2011 | US20110112191 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using same |
| 05/12/2011 | US20110112190 Orally active curcuminoid compounds |
| 05/12/2011 | US20110112189 Methods of treating pains associated with neuroma, nerve entrapment, and other conditions |
| 05/12/2011 | US20110112188 Treatment of Inflammatory Conditions |
| 05/12/2011 | US20110112187 Use Of Tranilast And Derivatives Thereof For The Therapy Of Neurological Conditions |
| 05/12/2011 | US20110112186 Diagnostic methods |
| 05/12/2011 | US20110112184 Compounds with glycidic structure active in the therapy of systemic and local inflammation |
| 05/12/2011 | US20110112183 Oligomer-Bis-Chromonyl Compound Conjugates |
| 05/12/2011 | US20110112182 Design, synthesis and functional characterization of rottlerin analogs |
| 05/12/2011 | US20110112181 Polyphenol compounds with modulating neurotransmitter release |
| 05/12/2011 | US20110112180 Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 05/12/2011 | US20110112178 Compositions And Methods For Inhibiting Expression Of IKK-B Gene |
| 05/12/2011 | US20110112177 Human G-Protein Coupled Receptor (HETGQ23) |
| 05/12/2011 | US20110112176 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | US20110112175 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112174 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112173 Methods and compositions involving microrna |
| 05/12/2011 | US20110112172 SDF-1 Binding Nucleic Acids |
| 05/12/2011 | US20110112171 Compositions and their uses directed to ptpru |
| 05/12/2011 | US20110112170 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity |